Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
03/2012
03/14/2012EP2428230A1 Probe for auditory hair cells.
03/14/2012EP2428226A1 Antibody targeting compounds
03/14/2012EP2428209A1 Drug suitability assessment method for prevention or treatment of anxiety disorders using cholinergic type ii theta rhythm
03/14/2012EP1290461B1 Method for investigating the fate of a test compound with nmr spectroscopy
03/14/2012CN102372771A Tumor targeted molecule and application thereof
03/14/2012CN102370995A Contrast agent nanocapsule with whole-sealing hollow structure and template-method assembling technology
03/14/2012CN102370994A Penicillin drug skin test reagent and preparation method thereof
03/14/2012CN102370985A Purpose of agonist of natriuretic peptide receptor A in pain management
03/14/2012CN102370623A Liquid-state lipid micro-particles used for delivering cerebric medicine through olfactory pathway, preparation method thereof, and preparation thereof
03/14/2012CN102370614A Polar medicine
03/14/2012CN101090710B Loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
03/13/2012US8133983 Agonistic binding molecules to the human OX40 receptor
03/13/2012US8133473 Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
03/13/2012CA2505527C Method for suppressing immune system response to transplanted tissue or cells
03/13/2012CA2457015C Method for inducing selectively suppressed immune response
03/13/2012CA2326959C Treatments for spinal muscular atrophy
03/13/2012CA2256308C Antibodies to the ed-b domain of fibronectin, their construction and uses
03/08/2012WO2012031250A2 Compositions for labeling nerves and methods of use
03/08/2012WO2012030675A1 Systems, methods, and devices for plasmid gene transfection using polymer-modified microbubbles
03/08/2012WO2012030166A2 Iron oxide nanocapsule, method of manufacturing the same, and mri contrast agent using the same
03/08/2012WO2012030134A2 Iron oxide nanocapsules, method of manufacturing the same, and mri contrast agent using the same
03/08/2012WO2011090349A9 Nanocarrier having enhanced skin permeability, cellular uptake and tumour delivery properties
03/08/2012US20120060231 Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody
03/08/2012US20120060229 Method For Characterising The Biological Activity Of Helminth Eggs, In Particular Trichuris Eggs
03/08/2012US20120059244 Skin marker
03/08/2012US20120059240 Method for preparation of micellar hybrid nanoparticles for therapeutic and diagnostic applications and compositions thereof
03/08/2012US20120058054 Gadolinium complex, method for preparing same, and mri contrast agent comprising same
03/08/2012US20120058052 Method for avian sex determination
03/08/2012US20120058051 Anti-human ror1 antibodies
03/08/2012US20120058050 Loaded latex optical molecular imaging probes containing lipophilic large stokes shift dyes
03/08/2012US20120058049 Cromolyn derivatives and related methods of imaging and treatment
03/08/2012CA2810217A1 Anti-cxcl13 antibodies and methods of using the same
03/08/2012CA2809864A1 Identification and enrichment of cell subpopulations
03/07/2012EP2425817A1 Polymerized micelles for diagnosis
03/07/2012EP2424574A2 Nanoparticle contrast agents for diagnostic imaging
03/07/2012EP2424573A2 Labeled molecular imaging agents, methods of making and methods of use
03/07/2012CN1549721B Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
03/07/2012CN102366632A Paramagnetic metal complex functionalized fluorogold nano-cluster magnetic resonance and fluorescence imaging contrast agent
03/06/2012US8129335 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry
03/06/2012US8128908 Nanoparticles and their use for multifunctional bioimaging
03/06/2012CA2452474C Nucleotide compositions comprising photocleavable markers and methods of preparation thereof
03/01/2012WO2012027570A2 Dual variable domain immunoglobulins and uses thereof
03/01/2012WO2012027493A1 Molecular imaging of cancer cells in vivo
03/01/2012WO2012027274A2 Compositions and methods for imaging
03/01/2012WO2012027204A1 End-capped polymers
03/01/2012WO2012026608A1 Polymeric particle and hydrophilic dye having a sulfonate group encapsulated within the particle
03/01/2012WO2012026316A1 Switching fluorescent nanoparticle probe and fluorescent particle imaging method using same
03/01/2012WO2012025167A1 Animal model for the evaluation of the efficacy of an hiv vaccine
03/01/2012WO2012025055A1 Methods and kits for predicting the risk of diabetes associated complications using genetic markers and arrays
03/01/2012US20120053232 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN TUMOR SUPPRESSING SUBTRANSFERABLE CANDIDATE 4 (TSSC4)
03/01/2012US20120052018 Smmr (small molecule metabolite reporters) for use as in vivo glucose biosensors
03/01/2012US20120052017 Method for producing contrast agent for optical imaging
03/01/2012US20120052016 Reconstitutable Microsphere Compositions Useful As Ultrasonic Contrast Agents
03/01/2012US20120052015 End-capped polymers
03/01/2012US20120052014 Ferritin biosensor and methods of using the same
03/01/2012US20120052013 Methods of Measuring Activities of Daily Living
03/01/2012US20120052012 Highly biocompatible dual thermogelling chitosan/glucosamine salt compositions
03/01/2012US20120052011 Composition and a method for producing contrast agent using the composition
03/01/2012US20120052006 Gold/lanthanide nanoparticle conjugates and uses thereof
03/01/2012US20120052005 Combination therapy to improve drug efficiency
03/01/2012US20120052004 Carbon nanotube based magnetic resonance image contrast agents
03/01/2012US20120052003 Microorganisms for preventing and treating neoplasms accompanying cellular therapy
03/01/2012CA2811993A1 Animal model for the evaluation of the efficacy of an hiv vaccine
03/01/2012CA2809433A1 Dual variable domain immunoglobulins and uses thereof
02/2012
02/29/2012EP2422618A1 Animal model for the evaluation of the efficacy of an HIV vaccine
02/29/2012CN102365099A Bonding products of aminated polysaccharides
02/29/2012CN101822846B Magneto-optical dual-mode molecular image probe and preparation method thereof
02/29/2012CN101768210B Tumor targeting polypeptide and preparation method thereof
02/29/2012CN101480494B Magnetic resonance contrast agent based on humanized antibody for diagnosing tumor
02/29/2012CN101281810B Surface finished magnetic nano crystal dry powder with activated oxatyl and preparation method thereof
02/28/2012US8124806 Contrast agents
02/28/2012US8124749 Targeted cell death
02/28/2012US8124725 PDGF-Rβ binders
02/28/2012US8124592 Development of a preventive vaccine for filovirus infection in primates
02/28/2012US8124349 Toll-like receptor assays
02/28/2012US8124101 Genetically engineered swine influenza virus and uses thereof
02/28/2012US8124067 Method for immunotherapy of tumors
02/28/2012US8124056 High throughput genetic screening of lipid and cholesterol processing using fluorescent compounds
02/28/2012US8124055 Peptide facilitating the entry of a linked molecule into a mammalian cancer cell; Using copper binding protein as a delivery vehicle; used to inhibit angiogenesis that accompanies tumor development
02/28/2012CA2353468C Radioconjugation of internalizing antibodies
02/23/2012WO2012024634A2 Environmentally-responsive nanocomposites and methods of their use
02/23/2012WO2012024592A2 Compositions, methods, and systems comprising fluorous-soluble polymers
02/23/2012WO2012024543A1 Circulating biomarkers for disease
02/23/2012WO2012023590A1 Method for quantitative measurement of gastric acidity using 13c carbonate salt
02/23/2012WO2012022932A1 Process for producing radiohalogenated bioconjugates and products thereof
02/23/2012WO2012022885A1 Method for determining physical characteristics of nanoparticles or agglomerates of nanoparticles, and device for implementing such a method
02/23/2012WO2012022299A1 Molecular switch
02/23/2012US20120045432 B lymphocyte stimulator assays
02/23/2012US20120045399 Positively-charged superparamagnetic iron oxide nanoparticle, contrast agent using the same and method of preparing the same
02/23/2012US20120045398 Method For The Manufacture Of Nanoparticle Complexes And Triblock Polymer Ligands And Products Thereof
02/23/2012US20120045397 Ultrasonically-triggered drug vehicle with magnetic resonance imaging function
02/23/2012US20120045396 Porous structures with modified biodegradation kinetics
02/23/2012US20120045395 MicroRNAs In Idiopathic Pulmonary Fibrosis
02/23/2012US20120045394 Human and mouse targeting peptides identified by phage display
02/23/2012US20120045393 Lhrh-ii peptide analogs
02/23/2012US20120045392 Pyro-glutamate a beta targeting agents
02/23/2012US20120045391 Formulations Targeting IGFBP7 for Diagnosis and Therapy of Cancer
02/23/2012CA2808809A1 Method for quantitative measurement of gastric acidity using 13c carbonate salt
02/23/2012CA2804333A1 Nalbuphine-based formulations and uses thereof
02/22/2012EP2419440A1 Peptide ligands for clusterin and uses thereof
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 354